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Abstract
Background: There is no definitive method of accurately diagnosing appendicitis before surgery. We evaluated the
feasibility of collecting breath samples in children with abdominal pain and gathered preliminary data on the
accuracy of breath tests.
Methods: We conducted a prospective pilot study at a large tertiary referral paediatric hospital in the UK. We
recruited 50 participants with suspected appendicitis, aged between 5 and 15 years. Five had primary diagnosis of
appendicitis. The primary outcome was the number of breath samples collected. We also measured the number of
samples processed within 2 h and had CO2 ≥ 3.5%. Usability was assessed by patient-reported pain pre- and post-
sampling and user-reported sampling difficulty. Logistic regression analysis was used to predict appendicitis and
evaluated using the area under the receiver operator characteristic curve (AUROC).
Results: Samples were collected from all participants. Of the 45 samples, 36 were processed within 2 h. Of the 49
samples, 19 had %CO2 ≥ 3.5%. No difference in patient-reported pain was observed (p = 0.24). Sampling difficulty
was associated with patient age (p = 0.004). The logistic regression model had AUROC = 0.86.
Conclusions: Breath tests are feasible and acceptable to patients presenting with abdominal pain in clinical
settings. We demonstrated adequate data collection with no evidence of harm to patients. The AUROC was better
than a random classifier; more specific sensors are likely to improve diagnostic performance.
Trial registration: ClinicalTrials.gov, NCT03248102. Registered 14 Aug 2017.
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Introduction
Exhaled breath tests from patients have previously been
tested as a method to predict respiratory, liver and infec-
tious diseases [1–6]. These tests detect the presence of
key volatile organic compounds (VOCs) that provide a
unique biomarker for the disease.
Exhaled breath tests may be useful in the diagnosis of
common abdominal conditions. For some gastrointes-
tinal conditions including acute appendicitis, halitosis, or
fetor, is a commonly reported symptom [7, 8]. Halitosis
is thought to be due to the creation of organic com-
pounds that are a byproduct of bacterial infection.
Primary diagnosis halitosis has previously been identified
using VOC analysis [9].
Acute appendicitis is a common condition in children
[10, 11]; however, timely and accurate diagnosis remains
challenging despite access to multiple diagnostic modal-
ities. Delayed diagnosis is frequent (reported as being up
to 60%) and associated with increases in appendix per-
foration rate from 21 to 71% [12]. Perforation is associ-
ated with significant increases in morbidity, length of
stay and cost [13, 14]. False-positive diagnosis leading to
unnecessary surgery has been estimated at 10–12% [15, 16].
Delayed diagnosis is thought to be due to variable, non-
specific presentation [17]. In children, diagnosis is further
complicated by the inability to articulate symptoms.
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The possibility of improving the accuracy of appendi-
citis diagnosis in the paediatric patient population is
highly appealing. An exhaled breath test has the poten-
tial to be less expensive and invasive than current blood
test or imaging diagnostic techniques, especially if it can
provide equivalent effectiveness.
The feasibility of exhaled breath tests requires the test
to be tolerated by those with suspected appendicitis. The
vast majority of these patients present with abdominal
pain, and it is currently unknown whether breath tests
would exacerbate the pain. In addition, any collected
breath data must be of sufficient quality for analysis and
must be processed in a timely manner for clinical deci-
sion making. In this study, we investigate these feasibility
issues. A secondary objective was to obtain preliminary
information on the composition of VOCs in children,
with and without appendicitis. These data will inform
future studies.
Methods
Study design
This was a single-centre prospective pilot study con-
ducted in a large tertiary referral paediatric hospital.
Approval for this study was obtained from the NHS
Research Ethics Committee (REC No. 17/WM/0151) and
registered with ClinicalTrials.gov (ID: NCT03248102). Ap-
proval for use of all equipment was obtained from the
hospital trust’s Medical Physics and Infection Control
units.
Participants
Children aged between 5 and 15 inclusive, presenting
with suspected appendicitis, were recruited. These
were typically patients who had been referred to the
paediatric surgical team after presentation via the
Emergency Department or the Children’s Assessment
Unit or through direct referral from another team or
hospital. Participants came from a non-consecutive
convenience sample, based on the availability of the
research assistant.
The research assistant (MI) was a medical student
who was supervised by a consultant paediatric surgeon
(JS). In addition to 24-h access to the consultant, the re-
search assistant had additional support available from
two other senior members of the consultant staff and a
paediatric surgical registrar (VL). The RA was available
during ‘office hours’ Monday to Friday subject to his
course commitments. In addition, when available, he
collected samples in the evenings and weekends.
Participants were excluded if they had a known alter-
native cause of abdominal pain (e.g. Crohn’s disease) or
if they had been admitted and discharged before a re-
searcher was able to obtain consent.
Data collection
Participant characteristics and clinical data
Baseline characteristics were collected for each partici-
pant. These were age in months, sex and admission date
and time. The following clinical data were also collected:
operation date and time, current medication, current use
of antibiotics and histopathological diagnosis.
Breath sample data
The research assistant was alerted to the presence of a
patient with suspected appendicitis by the clinical team.
Initially, they met the patient and their family to discuss
the study and provided an age-specific patient and
parent/guardian information sheet. Informed written
consent was sought from the parent/guardian of the po-
tential participant, and patients were excluded if consent
was not provided. A patient or their parent/guardian
was able to verbally withdraw from the study during
their in-patient stay and via written request up to the
point of completion of data analysis.
After consent, a single breath sample was collected
from recruited participants via a custom-made mouth-
piece attached to a Tedlar® bag primed with 200 μl of
distilled water. The process of collecting a breath sample
was as follows. The participant was seated and asked to
rest for 5 min prior to sampling. The participant was
then instructed to take a large breath in and exhale via
the mouthpiece. After 4 s, the researcher capped the end
of the mouthpiece so that the Tedlar® bag was filled with
the end-tidal fraction of breath. The end-tidal, or alveolar,
fraction was required to ensure reliable breath compos-
ition [18]. Breath samples can be classified as alveolar if
the %CO2 ≥ 3.5% [19].
Further exhaled breaths were collected in the same
bag in the event of insufficient breath volume (as deter-
mined by visual inspection). Alongside the breath sample
itself, the date and time of the sample, participant pain
(scored 0–10) before and after breath collection and
difficulty of breath collection (scored 0–10) were also
collected. Pain assessment scores between 0 and 10 are
common in clinical care [20] and have been validated in
paediatric cohorts [21].
VOC data
Breath samples were transported at room temperature
for analysis using a Bloodhound® electronic nose (e-
nose) attached to a laptop PC, which contained 12 non-
specific sensors. The e-nose equipment was kept in a
room adjacent to the paediatric surgical ward, in which
room temperature and humidity were monitored. The
output of the e-nose is a VOC signature. Each VOC sig-
nature is a 30-s 12-channel time series (Fig. 1). The e-
nose recording frequency is 4 Hz, leading to 1440 data
points per VOC signature. Each sample of breath was
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repeatedly processed until a consistent VOC signature
was obtained, as there is an initial ‘warm-up’ period dur-
ing which the readings can vary significantly. To reduce
the level of noise in the final time series, all analyses
were undertaken on the average of the last three signa-
tures for each patient.
Data storage and cleaning
VOC data were stored electronically and assigned a file-
name containing the study ID. All other data were collected
on paper case report forms and transcribed into an elec-
tronic database by SR and DW. In addition, the start and
end time of analysis and the %CO2 contained in the breath
sample were recorded. A total of 5 forms (10%) were ran-
domly selected using MATLAB’s randperm function [22]
and reviewed by VG to validate integrity of transcription.
Objectives
Primary feasibility objectives
The primary outcome was the number of successful
breath samples collected. Success was measured in terms
of the following:
– Percentage of breath samples processed within 2 h
– Percentage of breath samples with %CO2 ≥ 3.5%
– Difference in patient-reported pain before and after
breath collection
– User-reported ease of breath collection
Secondary objectives
The secondary objective was to explore the potential of
using the VOC signatures to differentiate between pa-
tients with and without appendicitis.
Sample size
Sample size was chosen to enable accurate estimation of
the proportion of successful breath sample collection (n)
and to provide a minimum number of appendicitis pa-
tients (m) for exploratory analysis. To ensure both objec-
tives were met, patients were planned to be recruited
until n ≥ 50 AND m ≥ 5. The number of cases was de-
termined so that at least preliminary performance of the
breath test could be derived. An estimated appendicitis
incidence rate of 10% was based on unpublished baseline
data from 2400 referred to our centre with suspected ap-
pendicitis. The expected sample size was 50 patients.
Analysis
Primary feasibility outcomes
The rate of successful breath sample collection was cal-
culated as the proportion of study participants from
which we obtained a VOC signature. The difference in
patient-reported pain (pain after − pain before) was
assessed using a two-sided Wilcoxon signed rank test.
Associations between difficulty of breath collection, pa-
tient age and pain after breath collection were visualised
using pair-wise scatter plots, and Spearman correlation
coefficients, r, were reported. 95% confidence intervals
were estimated by converting r into a z-score using the
Fisher transformation.
Secondary outcomes
The VOC signature of each participant was summarised
into one value per sensor channel to avoid overfitting,
by integrating each channel over time. We normalised
the integrated VOC signatures to have a mean of zero
and standard deviation of one. Due to a limited sample
Fig. 1 Example of a single VOC signature with 12 sensors. The time captured includes three phases: a a small warm-up phase (0–2 s), b the
sensor readings as the sample is passed through the device (2–13 s) and c a post-sample phase consisting of noise in the sensors whilst the
device is reset (17–30 s)
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size, we fitted a logistic regression with L1 regularisation
at strength 0.1 (i.e. a Lasso regression [23]) to model any
association between the summarised VOC signatures
and definitive appendicitis. Model performance was re-
ported via a confusion matrix. In addition, precision, re-
call and F1 score (harmonic mean of precision and
recall) of the model at a threshold of 0.5 were reported.
Point estimates were calculated on the original data
whilst 95% CIs were calculated using 1000 bootstrap
samples.
Precision and recall are defined as [24]:
Precision ¼ True positives
True positivesþ False positives
Recall ¼ True positives
True positivesþ False negatives
We also reported an overall measure of model per-
formance, the area under the receiver operator charac-
teristic curve (AUROC) [25].
Results
Fifty-eight participants were recruited to the study be-
tween August 2017 and January 2018. Of these, eight
participants did not meet the inclusion criteria and were
excluded from analysis (Fig. 2).
The primary diagnosis was unclear in two cases. One
case was classified histologically as ‘peri-appendicitis’
with normal mucosa, and the other as inflammatory
bowel disease. In both cases, there was evidence of in-
flammation at the appendix, but the cases were deemed
not to be primary diagnosis appendicitis. Baseline clin-
ical data are reported in Table 1.
Primary feasibility outcomes
Breath samples were collected from all 50 (100%) patients
who met the study inclusion criteria, between August
2017 and January 2018.
Breath samples were processed within 2 h in 36/45
(80%) of patients. Of the 45, 44 (98%) were processed
within 3 h. Processing time was not recorded for 5
participants.
The median difference in pain (scored 0–10) evaluated
before and after the breath sample was 0 (IQR 0 to 0,
range − 2 to 2); there was no significant change in re-
ported pain using the two-sided Wilcoxon signed rank
test (p = 0.49). For the five participants with confirmed
appendicitis, two had a decrease in pain, one had an in-
crease and two had no change in reported pain.
The median difficulty of sample collection (scored 0–10
by MI) was 4. There was moderate correlation between
difficulty of collection and participant age (Spearman r =
− 0.43, 95% CI − 0.60 to − 0.22, Fig. 3). There was no cor-
relation between difficulty of collection and reported pain
before the sample (Spearman r = − 0.11, 95% CI − 0.33 to
0.12), or between pain and participant age (Spearman r =
0.14, 95% CI − 0.09 to 0.36).
Breath samples had CO2 ≥ 3.5% (indicating alveolar
breath) in 19/49 (39%) of patients. Of the 19, 3 were
later confirmed to have had appendicitis. The mean age
and standard deviation in the alveolar breath group was
11.1 years (s.d. = 2.9), in contrast to 10.3 years (s.d. = 2.8)
for those that did not provide alveolar breath. The differ-
ence was not statistically significant (two-tailed T test
P = .31). CO2 was not recorded for one participant.
Fig. 2 Study enrolment flow diagram
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Secondary outcomes
Lasso regression [22] trained on the integrated VOC sig-
natures of all included patients produced a model with
six statistically significant parameters: 5 of the integrated
sensor readings and a constant bias term. The full con-
fusion matrix is given in Table 2, and results are further
summarised in Table 3.
Thirteen of the 50 patients were predicted as having
appendicitis (at a threshold of 0.5) of which 4 actually
had appendicitis, giving a positive predictive value of
0.31 (95% CI = [0.31, 0.71]). The negative predictive
value was 0.97 (95% CI = [0.96, 0.98]). The sensitivity of
the model was 0.83 (95% CI = [0.71, 0.83]), and specifi-
city was also 0.83 (95% CI = [0.73, 0.86]). The area under
the receiver operator characteristic curve (AUROC) for
this model was 0.83 (95% CI = [0.71, 0.83]).
One patient with appendicitis was misclassified; con-
temporaneous notes showed that the clinical researcher
expressed doubt about the quality of the associated
breath sample, but no further information was available.
Furthermore, of the five positive cases, this sample had
the lowest %CO2.
Discussion
Exhaled breath tests are feasible in children aged 5–15
with abdominal pain. In all but one case, approached par-
ticipants were recruited and breath was collected success-
fully. In the single case that consent was declined, the
participant’s guardian withdrew the participant from the
study before breath collection was attempted. Breath col-
lection was not associated with increased reported pain.
This extends results in similar exhaled breath condensate
tests in children without pre-existing pain [26, 27].
The ability to collect samples was satisfactory when
evaluated by our investigator. Although samples were
successfully obtained in all cases, we identified an associ-
ation between the age of the participant and lower diffi-
culty in obtaining a breath sample. It seems likely that
breath collection from children aged under 5 will be
harder to achieve. Younger children have the highest risk
of delayed diagnosis and perforation and may obtain
most benefit from improvements to diagnosis [28]. The
results highlight the potential utility of breath collection
systems designed specifically for younger children.
Alveolar breath was only obtained in 39% of patients.
The presence of alveolar breath was not associated with
participant age or diagnosis of appendicitis.
Of the 45 samples for which sample turnaround time
was recorded, 36 were processed within 2 h and 44
Table 1 Baseline clinical data
Non-appendicitis (n = 45) Appendicitis (n = 5)
Sex
Female 21 2
Male 24 3
Mean age in years (std) 10.6 (2.9) 9.9 (2.9)
Operated?
Yes 2 5
No 43 0
Regular medication
Yes 3 0
No 33 5
Not recorded 9 0
Antibiotics
Yes 2 5
No 43 0
Fig. 3 Negative correlation between age and difficulty of sample collection (y = 7.6–0.03x, Pearson R = − 0.396)
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within 3 h. This indicates that test results can be made
available within a clinically relevant timeframe. We note
that the time to process samples depended on the work-
load of the research assistant and is therefore an upper-
bound estimate of time required.
Exploratory data analysis used a logistic regression
model to predict appendicitis cases. Whilst the sample
size was not designed to determine test accuracy, initial
results were promising, especially as the VOC sensors
were not specifically designed to detect appendicitis.
Four of 5 (80%) appendicitis cases were correctly classi-
fied, and 34/45 (76%) negative cases were also correctly
classified. These figures are similar to those achieved
using traditional biomarkers such as white cell count
[29], though our small sample size means that direct
comparison is not appropriate.
To the best of our knowledge, this is the first attempt
to show that VOC biomarkers may have discriminatory
power to diagnose appendicitis.
Two of 5 breath samples that corresponded to appen-
dicitis cases did not contain alveolar breath. Of these,
one had %CO2 = 3.47, very close to the threshold, and
was classified correctly. The single misclassified case of
appendicitis had a much lower %CO2, 2.79%. These re-
sults provide weak initial evidence to suggest that alveolar
breath is necessary for the classification of appendicitis.
Whilst limited resources precluded better quality control
of breaths, we note that specific breath devices that meas-
ure %CO2 at the point of breath collection are available
[30]. Future work should examine whether both non-
alveolar and alveolar breath is adequate for diagnosing of
appendicitis.
Limitations
One potential limitation of this study is the use of sub-
jective measures for measuring endpoints. A 0–10 scale
was used to determine whether pain increased or de-
creased before and after breath sampling. This scale has
been validated in cohorts with children as young as 6
years old, and no other popular scale has been validated
in 5-year-olds [21, 30]. Differences in interpretation of
pain by study participants may mean that this method
can only accurately determine whether pain increased or
decreased; it cannot be used to assess the magnitude of
the change. Similarly, difficulty in sample collection was
also measured on a subjective 0–10 scale. In this case,
the use of a single researcher reduced inter-rater reliabil-
ity. This means that comparisons are more reliable, but
the absolute magnitude is not.
This study was not powered to assess the performance
of VOC analysis in detecting appendicitis. Whilst the re-
ported AUROC of 0.83 is much greater than for the null
model (that is, random guessing), the figures are based
on a very small number of positive appendicitis cases.
Additionally, we used an array of sensors that were not
specifically targeted towards likely appendicitis VOCs.
Development of disease-specific sensors from mass spec-
trometry studies would likely improve overall accuracy.
The gold standard for diagnosis was appendix histology.
This may underestimate the true number of positive cases
if a patient was mis-diagnosed as non-appendicitis, but
presented at another hospital if symptoms persisted. As
our centre is a regional unit, the likelihood of this situ-
ation is minimal.
Finally, we did not correct for potential confounders
such as the presence or absence of guarding and the
presence or absence of a coryzal illness. Although we
initially considered these variables, poor inter-rater reli-
ability meant that we considered the data too poor for
practical use. Follow-on work could consider longitu-
dinal changes in VOC, particularly if an appendectomy
had been performed. In our case, this was not possible
due to limitations in resource.
Generalisability
Our results show that bedside breath-test style tests are
plausible in an acute paediatric setting. For the first time,
we demonstrate that this is the case even for those ex-
periencing pain. For VOC analysis specifically, we have
demonstrated that data can be collected and analysed in
a timely manner. Timeliness in this setting means two
things. First, that VOC processing occurs before the bio-
marker signal degrades. Second, that processing is fast
enough to influence clinical decisions. We have esti-
mated 2 h as a reasonable period of time in which to ob-
tain a result, and this was possible for most patients.
Whilst our result is device-specific, the process of breath
capture into temporary storage containers before ana-
lysis is typical [31].
Further work is required to examine clinical validity
and clinical utility. Even if VOC analysis demonstrates
the ability to differentiate between appendicitis and non-
appendicitis, it must demonstrate improved outcomes in
Table 3 Classification table for the Lasso regression model
Precision Recall F1 score Support
No appendicitis 0.97 0.80 0.88 45
Appendicitis 0.31 0.80 0.40 5
Weighted average 0.91 0.80 0.83
Classification table summarising the model that uses VOC signatures to predict
appendicitis, with a weighted average of each column based on the number
of positive and negative patients.
Table 2 Confusion matrix for the Lasso regression model
Predicted negative Predicted positive
No appendicitis 36 9
Appendicitis 1 4
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comparison with the current diagnostic techniques be-
fore introduction into clinical practice.
Conclusion
Our pilot evaluation study showed that breath collection
for VOC can be successfully and consistently collected
in an acute paediatric setting. Results of exploratory data
analysis to determine VOC analysis accuracy are promis-
ing. These data will inform further investigations using
appendix-specific sensors, on a larger population, to
confirm sensitivity and specificity [32].
Abbreviation
VOC: Volatile organic compounds
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